Home » Topics » Regulatory » Patents

Patents
RSS

Retinoid series for cancer

Feb. 14, 1997

Anti-factor Xa compounds disclosed by RPR

Feb. 14, 1997

X-ray contrast agents from Schering AG

Feb. 14, 1997

Human Genome Sciences describes MCP-4 polypeptide

Feb. 14, 1997

ZymoGenetics/Novo Nordisk isolate anticlotting agent

Feb. 14, 1997

EPO activators/agonists described by J&J and Affymax

Feb. 14, 1997

Neutrophil-stimulating peptides derived from TNF described by Peptech

Feb. 13, 1997

Pfizer claims 5-LO inhibitors

Feb. 13, 1997

Sugen reports modulators of tyrosine signal transduction

Feb. 13, 1997

Anticancer agents from Takeda

Feb. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...